Uzoigwe, Chioma http://orcid.org/0000-0002-6853-7117
Radin, Michael
Hamersky, Carol M.
DeKoven, Mitch
Holt, Cassie
Karkare, Swapna
Polonsky, William H.
Funding for this research was provided by:
Novo Nordisk
Article History
Accepted: 28 December 2020
First Online: 7 February 2021
Compliance with ethical standards
:
: <i>Chioma Uzoigwe</i>, <i>Michael Radin</i>, and <i>Carol M. Hamersky</i> are employed by Novo Nordisk, Inc., the study sponsor. <i>Mitch DeKoven</i> and <i>Swapna Karkare</i> are employed by IQVIA, which received funding from Novo Nordisk, Inc. for work performed on this study under a contract between IQVIA and Novo Nordisk, Inc. <i>Cassie Holt</i> was employed by IQVIA when the study was conducted; she is now employed by Novo Nordisk, Inc. <i>William H. Polonsky</i> served as a consultant and has received consultant fees from Novo Nordisk. William H. Polonsky has also served as a consultant for Sanofi, and Eli Lilly and Company.
: Central Institutional Review Board approval was obtained from the New England Independent Review Board on October 30, 2017. The study conformed with the Helsinki Declaration of 1964, as revised in 2013, concerning human and animal rights, and Springer’s policy concerning informed consent has been followed.
: Informed written consent was obtained from all individual participants included in the study.